Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-0233 Copyright © 2008 by The Endocrine Society
Compound Heterozygous Mutations in the GNAS Gene of a Boy with Morbid Obesity, Thyroid-Stimulating Hormone Resistance, Pseudohypoparathyroidism, and a Prothrombotic StateKathleen Freson, Benedetta Izzi, Jaak Jaeken, Monique Van Helvoirt, Chantal Thys, Christine Wittevrongel, Francis de Zegher and Chris Van GeetCenter of Molecular and Vascular Biology (K.F., B.I., C.T., C.W., C.V.G.) and Department of Pediatrics (J.J., M.V.H., F.d.Z., C.V.G.), University Hospital Gasthuisberg, University of Leuven, B-3000 Leuven, Belgium Address all correspondence and requests for reprints to: Kathleen Freson, Center for Molecular and Vascular Biology, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail: Kathleen.freson{at}med.kuleuven.be.
Context: Pseudohypoparathyroidism type Ia and pseudopseudohypoparathyroidism are characterized by Albrights hereditary osteodystrophy (AHO), respectively, with and without hormone resistance. Both clinical conditions result from decreased expression or function of the Objective: A genetic and functional GNAS study was undertaken in a boy with morbid obesity (body mass index Z-score of 5 at the age of 3 yr, with a body fat fraction of 40%, which is more than twice normal), TSH resistance, pseudohypoparathyroidism, and a prothrombotic state.
Results: The boy was found to be a first case with a compound heterozygous GNAS defect: a de novo R231C mutation on the paternal allele and on the other allele a maternally inherited unique combination of three C to T nucleotide substitutions in exon 7 (I185I), intron 7 (IVS7 + 31), and exon 13 (N371N) leading to aberrant splicing of GNAS. Platelets of this boy displayed a pronounced Gs Conclusion: This report expands the human GNAS genotype-phenotype spectrum to include compound heterozygosity and a prothrombotic state.
|